Why Adverse Events In Oncology Are So Difficult To Spot and CTCAE in Clinical Research

Documenting Adverse Events(AE) is crucial for determining the safety of a new medical treatment. Most studies tend to document an AE’s severity or relationship to study drug, but oncology asks for more. As seen in this video, there are levels to oncology AEs which may not be easy to identify without some level of experience in oncology trials.